NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts April 23, 2021   Policy Notices AHRQ Notice of Extension of PA-21-202 (NOT-HS-21-011) Agency for Healthcare Research and Quality Publication of the Revised NIH Grants Policy Statement (Rev. April 2021) for Fiscal Year 2021 (NOT-OD-21-107) National Institutes of Health Expanding Requirement for eRA Commons IDs to All Senior/Key Personnel (NOT-OD-21-109) National Institutes of Health Agency for Healthcare Research and Quality Food and Drug Administration General Notices Notice of Pre-Application Technical Assistance Webinar for RFA-AT-21-006, "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)" (NOT-AT-21-010) National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke Pre-Application Webinar for the Clinical Proteomic Tumor Analysis Consortium (CPTAC): RFA-CA-21-023 (U24), RFA-CA-21-024 (U24), and RFA-CA-21-025 (U01) (NOT-CA-21-072) National Cancer Institute Continuation of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00) During the COVID-19 Pandemic (NOT-DE-21-003) National Institute of Dental and Craniofacial Research NIDCR Policy on Applications for Investigator-Initiated Clinical Trials (NOT-DE-21-004) National Institute of Dental and Craniofacial Research Continuation of Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00) (NOT-GM-21-037) National Institute of General Medical Sciences Notice of Pre-Application Technical Assistance Webinar for RFA-MD-21-004, Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 Clinical Trial Optional) (NOT-MD-21-018) National Institute on Minority Health and Health Disparities Notice of Intent to Reissue PAR-18-845 Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) and PAR-18-846 (R21 - Clinical Trial Not Allowed) as a Notice of Special Interest (NOSI) (NOT-OD-21-113) Office of Disease Prevention National Cancer Institute National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences Notice of Intent to Reissue PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01- Clinical Trial Optional) and PAR-18-848 (R21 - Clinical Trial Optional) as a Notice of Special Interest (NOSI) (NOT-OD-21-114) Office of Disease Prevention National Cancer Institute National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute on Minority Health and Health Disparities Notice of Pre-Application Webinar for Phase II of the RADxSM-UP Initiative (NOT-OD-21-115) National Institutes of Health Request for Information (RFI): Seeking Stakeholder Input on Enhancing Cancer Health Disparities Research (NOT-CA-21-066) National Cancer Institute Request for information (RFI) on enhancing the science for the Environmental influences on Child Health Outcomes (ECHO) program (NOT-OD-21-108) National Institutes of Health National Institute of Allergy and Infectious Diseases Notice of Changes to Funding Opportunities Notice of NIAMS Participation in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)" (NOT-AR-21-020) National Institute of Arthritis and Musculoskeletal and Skin Diseases Notice of Change to NOT-OD-21-087, Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being (NOT-CA-21-065) National Cancer Institute Notice of Change to PAR-20-238, "Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)" (NOT-DA-21-037) National Institute on Drug Abuse National Cancer Institute National Heart, Lung, and Blood Institute National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Nursing Research National Library of Medicine Office of Behavioral and Social Sciences Research Office of Disease Prevention Notice of Change to PAR-20-214, "Research to Improve Native American Health (R21 Clinical Trials Optional)" (NOT-DA-21-038) National Institute on Drug Abuse National Institute on Minority Health and Health Disparities Notice of Requirement for Submission of Current and Pending Support Information for the PD(s)/PI(s) of PAR-20-115 Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase 3 - Transitional Centers (P30)" (NOT-GM-21-038) National Institute of General Medical Sciences Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-313 Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional) (NOT-GM-21-039) National Institute of General Medical Sciences Notice of Requirement for Submission of Current and Pending Support Information in PAR-19-312 Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional) (NOT-GM-21-045) National Institute of General Medical Sciences Notice of Additional Information for PAR-20-101, Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) (NOT-HD-21-028) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Early Termination of PAR-21-162, Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (NOT-NS-21-056) National Institute of Neurological Disorders and Stroke Notice of Early Termination of PAR-21-152, NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed). (NOT-NS-21-060) National Institute of Neurological Disorders and Stroke Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01) (NOT-AA-21-016) National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24) (NOT-AA-21-017) National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24) (NOT-AA-21-018) National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Translational and Basic Science Research in Early Lesions (TBEL) (U54 Clinical Trial Not Allowed) (NOT-CA-21-060) National Cancer Institute Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating and Data Management Center for Translational and Basic Science Research in Early Lesions (TBEL) (U24 Clinical Trial Not Allowed) (NOT-CA-21-061) National Cancer Institute Notice of Intent to Publish a Funding Opportunity Announcement for Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) (NOT-CA-21-068) National Cancer Institute Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Canine Cancer Immunotherapy Network (K9CIN; U24 Clinical Trial Not Allowed) (NOT-CA-21-069) National Cancer Institute Notices of Special Interest Notice of Special Interest (NOSI): Availability of Funds to defray Childcare Costs for NCI, NIA, NIDCR, NIDDK, and NIH Blueprint Predoctoral to Postdoctoral Fellow Transition Programs F99 Awardees (NOT-CA-21-053) National Cancer Institute National Human Genome Research Institute National Institute on Aging National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Neurological Disorders and Stroke Notice of Special Interest (NOSI): Administrative Supplements to Stimulate and Strengthen Global Cancer Survivorship Research (NOT-CA-21-058) National Cancer Institute Notice of Special Interest (NOSI): Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (NOT-DA-21-012) National Institute on Drug Abuse National Institute on Alcohol Abuse and Alcoholism Office of Research on Women's Health Notice of Special Interest (NOSI): Administrative Supplements to Promote Diversity for NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees (NOT-NS-21-047) National Institute of Neurological Disorders and Stroke Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for Administrative Supplements to Support Career Enhancement Related to Clinical Research on Pain (Admin Supp Clinical Trial Not Allowed) (NOT-NS-21-048) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Nursing Research Funding Opportunities NICHD Small Research Grant Program (R03 Clinical Trial Required) (PA-21-221) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): Multiple dates, see announcement. NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) (PA-21-231) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): Multiple dates, see announcement. NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed) (PAR-21-209) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse National Institute of Environmental Health Sciences Application Receipt Date(s): Multiple dates, see announcement. Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (PAR-21-233) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Mental Health Office of Behavioral and Social Sciences Research Application Receipt Date(s): August 10, 2021, February 9, 2022, August 9, 2022, February 9, 2023, August 9, 2023, February 9, 2024 NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) (PAR-21-234) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is June 12, 2021. Centers for HIV Structural Biology (U54 Clinical Trial Not Allowed) (RFA-AI-21-030) National Institute of Allergy and Infectious Diseases Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below. Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed) (RFA-DK-20-026) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): September 23, 2021 Kidney Precision Medicine Project Kidney Tissue Atlas Coordinating Center (U01 Clinical Trial Not Allowed) (RFA-DK-20-027) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): September 23, 2021 Kidney Precision Medicine Project Tissue Interrogation Sites (U01 Clinical Trial Not Allowed) (RFA-DK-20-028) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): September 23, 2021 Kidney Precision Medicine Project Central Hub (U24 Clinical Trial Not Allowed) (RFA-DK-20-029) National Institute of Diabetes and Digestive and Kidney Diseases Application Receipt Date(s): September 23, 2021 Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed) (RFA-HD-22-004) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): July 29, 2021 Pilot Effectiveness Trials of Interventions for Preschoolers with ADHD (R34 Clinical Trial Required) (RFA-MH-21-230) National Institute of Mental Health Application Receipt Date(s): Multiple dates, see announcement. NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) (RFA-NS-21-012) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health Office of Behavioral and Social Sciences Research Application Receipt Date(s): December 15, 2021; April 15, 2022; December 15, 2022; April 14, 2023; December 15, 2023.   Read More NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892